26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 14, 2025.

via HealthDay

THURSDAY, Aug. 14, 2025 -- In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August data brief published by the National Center for Health Statistics.

Anjel Vahratian, Ph.D., M.P.H., and Antonia Warren, from the National Center for Health Statistics in Hyattsville, Maryland, describe the percentage of adults with diagnosed diabetes who were taking an injectable GLP-1 RA medication based on data from the 2024 National Health Interview Survey.

The researchers found that the percentage of adults with diagnosed diabetes who used GLP-1 RA injectables was 26.5 percent in 2024; use increased with age, from 25.3 percent among adults ages 18 to 34 years to 33.3 percent among those aged 50 to 64 years, and then decreased to 20.8 percent among those aged 65 years and older. Compared with Asian non-Hispanic adults with diagnosed diabetes, Hispanic, Black non-Hispanic, and White non-Hispanic adults with diagnosed diabetes were more likely to use GLP-1 RA injectables (31.3, 26.5, and 26.2 percent, respectively, versus 12.1 percent). Among those with greater body mass index, GLP-1 RA injectable use was higher. Among adults with diagnosed diabetes, the likelihood of using GLP-1 RA injectables was higher for those who took insulin or oral glucose-lowering medications versus those who did not (31.3 and 28.1 percent, respectively, versus 24.5 and 22.2 percent, respectively).

"An analysis of data from the Medical Expenditure Panel Survey showed a 155 percent increase in the percentage of adults with type 2 diabetes who used GLP-1 injectables from 2018 (7.6 percent) to 2022 (19.4 percent)," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-08-15 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords